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Abstract
Background: The new gold standard for myocardial viability assessment is late gadolinium enhancement-
cardiovascular magnetic resonance (LGE-CMR); this technique has demonstrated that the transmural extent of scar
predicts segmental functional recovery. We now asked how the number of viable and number of viable+normal,
segments predicted recovery of global left ventricular (LV) function in patients undergoing CABG. Finally, we
examined which segmental transmural threshold of scarring best predicted global LV recovery.
Methods and Results: Fifty patients with reduced LV ejection fraction (EF) referred for CABG were recruited, and
33 included in this analysis. Patients underwent CMR to assess LV function and viability pre-operatively at 6 days
and 6 months. Mean LVEF 38% ± 11, which improved to 43% ± 12 after surgery. 21/33 patients improved EF by
≥3% (EF before 38% ± 13, after 47% ± 13), 12/33 did not (EF before 39% ± 6, after 37% ± 8). The only
independent predictor for global functional recovery after revascularisation was the number of viable+normal
segments: Based on a segmental transmural viability cutoff of <50%, ROC analysis demonstrated ≥10 viable
+normal segments predicted ≥3% improvement in LVEF with a sensitivity of 95% and specificity of 75% (AUC =
0.9, p < 0.001). Transmural viability cutoffs of <25 and <75% and a cutoff of ≥4 viable segments were less useful
predictors of global LV recovery.
Conclusions: Based on a 50% transmural viability cutoff, patients with ≥10 viable+normal segments improve
global LV function post revascularisation, while patients with fewer such segments do not. LGE-CMR is a simple
and powerful tool for identifying which patients with impaired LV function will benefit from CABG.
Trial registration: Research Ethics Committee Unique Identifier: NRES:05/Q1603/42. The study is listed on the
Current Controlled Trials Registry: ISRCTN41388968.
URL: http://www.controlled-trials.com
Background
In some patients with coronary artery disease and
impaired left ventricular (LV) function, revascularisation
by coronary artery bypass grafting (CABG) improves
both symptoms and prognosis[1], while in the absence
of significant viability, revascularisation offers little prog-
nostic benefit[2]. Several studies have directly linked
post-surgical improvement in LV ejection fraction (EF)
and symptoms to the presence of significant viable myo-
cardium[3-6]. Viability testing is now an integral part of
the assessment of patients with impaired LV function
* Correspondence: stefan.neubauer@cardiov.ox.ac.uk
1University of Oxford Centre for Clinical Magnetic Resonance Research,
(OCMR), UK
Full list of author information is available at the end of the article
Pegg et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:56
http://www.jcmr-online.com/content/12/1/56
© 2010 Pegg et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.and coronary artery disease considered for revascularisa-
tion[7].
Over the last decade, LGE-CMR has emerged as a
simple and highly reproducible tool for assessing both
myocardial injury and viability. The seminal work by
Kim et al.[5] demonstrated that the transmural extent of
myocardial injury predicted regional functional recovery
on a segmental level. However, even more important
than the issue of segmental recovery is the question of
identifying which patients with poor LV function will
show recovery of global LV function after revascularisa-
tion, and which will not. Studies using positron emission
tomography (PET) and Dobutamine Stress Echo (DSE)
have started to define the numbers of viable segments,
based on a 16 segment model, associated with global
functional recovery. Bax et al. demonstrated functional
recovery in patients with 4 or more viable segments on
DSE, with an approximate sensitivity of 84% and specifi-
city of 81%[8]. More recently Slart et al.[ 9 ]s h o w e dt h a t
3 or more viable segments defined by FDG uptake by
PET, predicted global functional recovery with a sensi-
tivity and specificity of 87% and 85%, respectively. How-
ever, unlike LGE-CMR, these methods cannot define the
segmental transmural extent of scar. With LGE-CMR
increasingly becoming the gold standard for viability
imaging, it is important to understand how both the
number of viable segments and the transmural extent of
viability, assessed by LGE-CMR, predicts global recovery
of LV function.
We have reported the results of a randomised trial
comparing cardioplegic arrest CABG (ONSTOP) to a
novel method for intra-operative myocardial protection
(on-pump beating heart, ONBEAT) [10]. This study
used CMR to image patients with heart failure under-
going CABG before, at 6 days and at 6 months after
surgery. Using data from this unique cohort, we asked
two simple, practical questions: Based on a 16 segment
AHA model (omitting the true apex), does the sum of
viable segments or the sum of viable+normal segments
provide the stronger cutoff criteria for global LV recov-
ery? Secondly, what cutoff for segmental transmural
extent of viability best predicts recovery?
Methods
The methods have been described in detail before[10].
Patients with impaired LV function accepted for surgery
were recruited if they consented and had no contra-indi-
cations to CMR or gadolinium contrast. Recruited
patients included both elective admissions and patients
with recent unstable coronary syndromes requiring
inpatient revascularisation; patients with Class IVb
angina were excluded. All elective patients were assessed
with CMR within 4 weeks of their surgery, whilst all
urgent in-hospital referrals for CABG underwent their
pre-operative CMR assessment the evening before sur-
gery. This study complies with the Declaration of Hel-
sinki, a locally appointed ethics committee had
approved the research protocol (NRES:05/Q1603/42), all
patients gave written informed consent.
Treatment and Procedures
The aim of CABG was to obtain complete revascularisa-
tion, all territories were assumed to be revascularised,
intra operative graft imaging was routinely undertaken.
CMR protocol
All CMR examinations were performed using a 1.5
Tesla MR scanner (Sonata, Siemens Medical Solutions,
Erlangen, Germany), using prospective gating. After
piloting, steady-state free precession cine images (tem-
poral resolution 24 - 45 ms; TE/TR 1.5/3.0 ms, flip
angle 60
o) were acquired. The short axis stack was
acquired parallel to the AV groove in 1 cm increments
(slice thickness 7 mm, inter-slice gap 3mm).
LGE-CMR was performed with a T1-weighted seg-
mented inversion-recovery turbo fast low-angle shot
(FLASH) sequence (echo time 4.8ms, voxel size 1.4 ×
2.4 × 7 mm, flip angle 20°) following a 6 minute time
delay after the administration of 0.1 mmol/kg contrast
agent (Gadodiamide, Omniscan™, GE Healthcare). The
inversion time was meticulously adjusted for optimal
nulling of remote normal myocardium.
Post Processing Analysis
The methods for analysing and calculating LV volumes
and LGE are standardised within our unit and, along
with the reproducibility, have been published [11,12].
Left ventricular volumetric analysis used the short axis
ventricular stack and was analysed using Argus software
(Version 2002B, Siemens Medical Solutions) by a single
experienced observer (J.M.F) blinded to RWM and LGE
findings. Manual tracing of endocardial borders in each
successive slice position at the chosen end diastolic and
end systolic phase was performed. The basal slice was
selected if its circumference comprised at least 50% of
myocardium. Papillary muscle was included in the LV
m a s sa n de x c l u d e df r o mt h eL Vv o l u m e .V i s u a la s s e s s -
ment of regional wall motion score (RWMS) using
Argus software (Version 2002B, Siemens Medical Solu-
tions) was undertaken by two experienced observers
working in consensus and blinded to the LGE findings.
Segments were graded 1-normally contracting to 5-dys-
kinetic. Improvement in regional contraction was
defined by an improvement of ≥1 functional grade (with
the exception of improvement from grade 5 to grade 4).
Transmural extent of myocardial infarction was quan-
tified by a computer assisted planimetry programme,
MATLAB version 7.3.0.267 (Natick USA) by a single
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Page 2 of 10experienced operator, with areas of myocardial infarc-
tion determined as areas with signal intensity >2 S.D
above remote normal myocardium. Semi-quantitative
approach with operator override was employed to cate-
gorize the transmural extent of hyperenhancement into
subgroups: 0 = no LGE, 1 = 1-25% LGE, 2 = 26-50%
LGE, 3 = 51-75% LGE and 4 > 75% LGE. Inter-observer
variability for transmurality grading was checked for 15
patients by a second blinded observer, with a kappa =
0.872, indicating a good level of agreement. To calculate
the mass of LGE, we assumed a specific gravity of 1.05
g/cm
3.
Registration of segments
For visual assessment of transmural extent of scar and
RWM, two models, based on either a 48 segment (6
slices × 8 segments) or the AHA 16 segment model
(excluding segment 17 - apex) was used. The basal slice
was defined as the first slice without LVOT in any
phase of the cardiac cycle. Segment 1 was defined at the
anterior insertion of the right ventricle into the inter-
ventricular septum. Registration of segments for LGE-
CMR and regional wall motion scores was undertaken
in a paired manner by a single observer 6 months prior
to visual analysis. For the 16 segment AHA model, the
mid-ventricular slice was defined as 20 mm below the
base, on condition that it contained papillary muscle but
no trabeculation, similarly the apical slice was defined as
20 mm below the mid ventricular slice on condition
that it contained trabeculation but no papillary muscle.
Statistical Analysis
There was an excess in myocardial injury associated
with the ONBEAT technique, therefore we excluded
patients with evidence of new myocardial injury based
on their early post operative scan or on the presence of
significantly elevated troponin levels following surgery
(in patients not able to complete imaging at 6 days).
The main comparisons of the study are between patients
with functional recovery and patients without improve-
ment in LVEF.
Values were expressed as mean (SD) or median (inter-
quartile range, 25% to 75%). The effect of revascularisa-
tion was compared using a paired t-test and dichoto-
mous data was compared by the c
2 statistic or Fisher’s
exact test. Continuous variables that were not distribu-
ted normally were compared by the Mann-Whitney test.
To compare the transmural extent of scar and regio-
nal functional recovery, a logistic generalised estimating
equation model accounting for non-independence of the
data within each subject was used. To examine the
impact of the number of non-viable segments on regio-
nal recovery in viable segments, a similar logistic gener-
alised estimating equation model was used, adjusting for
baseline LGE, surgical technique, ESVI and EF. For both
analyses, both the independent (no adjustments made
for within subject correlation of the data) and AR1
models (accounting for within subject correlation in the
d a t a )w e r ee x a m i n e dw i t hn oe f f e c to nt h er e s u l t s .T h e
AR1 model is reported. A probability of p < 0.05 was
considered statistically significant.
Due to the number of independent variables involved
in determining late LV recovery, we adopted a model
building strategy to assess the potential association
between baseline variables and change in EF at 6 months.
We first performed a simple regression analysis to exam-
ine any potential association between the baseline vari-
ables (i.e. age, sex, BMI, ONBEAT versus ONSTOP,
number of grafts, total mass of LGE, % Left anterior des-
cending artery (LAD) territory affected by >50% LGE,
number of viable segments, number of viable+normal
segments, time between surgery and CMR scan, pre-
operative LVEF and ESVI) and late change in EF. Vari-
ables with p < 0.1 were then included in the multiple lin-
ear regression using an enter selection method to assess
the best factors for predicting change in LV function.
Receiver Operating Characteristic (ROC) analysis was
performed to determine the number of viable segments,
and the number of viable+normal segments, that best
predicts recovery of global function, where improvement
is defined as ≥3%[13] absolute change in LVEF.
Results
Patients recruited and excluded from this study are pre-
sented in Figure 1. Data analysis is based on 33 patients.
Mean pre-operative LVEF for patients was 38% ± 11,
mean pre-operative regional wall motion score (RWMS)
was 2.4 ± 0.7. Eight patients had recent evidence (< 28
days) of acute coronary syndrome. There was an excel-
lent linear relationship between baseline EF and mean
RWMS for each individual patient (r = 0.85, p < 0.0001).
All patients recruited had three vessel coronary artery
disease or left main stem disease. The median number
of grafts per patient was 4(3-4), all grafts were patent at
the end of surgery. All patients were reviewed at 6
months, no patient had recurrent angina or an interven-
ing hospital admission.
Prediction of regional segmental functional recovery
Prior to defining predictors of global recovery we
wanted to ensure that the previously described relation-
ship between transmural extent of viability and regional
function recovery holds true for this cohort of patients
with more severely impaired LV function. For this pur-
pose it was necessary to use a 40 or 48 segment model
similar to previous work[5,14]. A total of 1408 segments
were available for analysis, of which 957 segments were
judged to be dysfunctional before revascularisation
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LGE (51%). In dysfunctional segments, there was pro-
gressive reduction in functional recovery with increasing
extent of transmural infarction (p < 0.001) (Figure 2).
Overall, patients improved their LVEF from 38% ± 11
to 43% ± 12 (p < 0.001). Of dysfunctional segments
affected by <50% LGE, 381/609 (63%) improved contrac-
tion by 6 months. Segments with <50%LGE were con-
sidered “viable” for this purpose. In patients, the
number of viable and viable+normal (<50% scar) seg-
ments, not the mass of LGE, had linear relationships
with the percentage of viable segments that demon-
strated recovery of function (Figure 3i and ii). This asso-
ciation was maintained after adjusting for baseline ESVI,
EF, surgical technique and the extent of LGE in these
viable segments (p < 0.001).
Patient response to coronary artery bypass grafting
An improvement in EF of ≥3% was demonstrated in 21/
33 patients (64%), and the characteristics of patients
with and without significant improvement in LVEF are
given in Table 1.
Prediction of global functional recovery based on the 16
segment AHA model
The relationship between the number of viable+normal
segments (< 50% transmural scar) (Figure 4, panel i)
Figure 1 Consort statement diagram of trial participants. AICD, automated implantable cardiac defibrillator; CABG, coronary artery bypass
grafting; CMR, cardiovascular magnetic resonance imaging; CVE, cerebro-vascular accident; LV, left ventricular.
Figure 2 Relationship between the transmural extent of scar
and functional recovery on a segmental basis.
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Page 4 of 10and change in EF was linear. A lesser relationship was
demonstrated when the number of viable segments was
considered (Figure 4, panel ii). Using a multivariate
model, only the sum of viable+normal segments (but
not the number of viable segments) was shown to
independently predict change in EF 6 months following
revascularisation (Table 2 and Figure 4, panel i).
ROC analysis was used to best define a threshold for
number of viable+normal segments and also the trans-
mural extent of LGE within each segment that had the
Figure 3 Panel i Correlation between recovery of remote and adjacent viable segments and the mass of late gadolinium
enhancement (LGE) before surgery. Panel ii Correlation between recovery of remote and adjacent segments with the number of viable
+normal segments.
Table 1 Patient demographics
All patients
(n = 33)
Responders
(n = 21)
Non-responders
(n = 12)
p value
Age 66 ± 8 67 ± 8 63 ± 8 0.15
GFR 65 ± 16 66 ± 18 64 ± 11 0.83
BSA(m
2) 2 ± 0.2 2 ± 0.2 2 ± 0.1 0.83
ONBEAT 12 5 7
ONSTOP 21 16 5 0.07
B Blocker 25 15 10 0.574
ACE inhibitor 27 12 19 0.493
AUC troponin 215 265 156 0.89
(0-120 h) (109-347) (103-346) (109-412)
Numbers of distal 4 3.5 4 0.31
anastomoses (3-4) (2.25-4) (3-4)
Duration between surgery and final CMR 217 ± 23 225 ± 29 204 ± 22 P = 0.04
EF(%) 38 ± 11 38 ± 13 39 ± 6 0.77
EDVI(ml.m
-2) 118 ± 33 120 ± 34 116 ± 32 0.76
ESVI(ml.m
-2) 75 ± 32 77 ± 36 72 ± 27 0.65
Mass of LGE(g) 28 ± 12 27 ± 11 28 ± 15 0.83
Viable+normal segments 11 ± 3 12 ± 2 8 ± 3 < 0.001
6 month EF(%) 43 ± 12 47 ± 13 37 ± 8 0.02
Responder is defined as improvement in EF (EF) ≥3%. BSA, body surface area (m
2); LGE, late gadolinium enhancement; EDVI, end diastolic volume index; ESVI,
end systolic volume index; ONBEAT, on-pump beating heart coronary artery bypass grafting; ONSTOP, conventional cardioplegic arrest coronary artery bypass
grafting.
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functional recovery (Figure 5). For improvement in
LVEF, 10 or more viable+normal segments (LGE <50%)
demonstrated the optimal sensitivity of 95% and specifi-
city of 75%. Furthermore, both the positive and negative
predictive values were high (87% and 89% respectively)
(AUC 0.90 p < 0.001, Figure 5). A transmural extent of
LGE <50% was the best threshold to define segmental
viability for the purpose of predicting global recovery,
while other transmural cutoff thresholds were less
powerful.
Patients with ≥10 viable+normal segments on LGE-
CMR demonstrated both significant improvement in EF
and reverse remodeling, whereas there was no evidence
o fac h a n g ei no v e r a l lf u n c t i o no rL Vg e o m e t r ya t6
months in patients with <10 viable+normal segments
(Table 3).
The number of viable segments correlated very well
with the mean change in regional wall motion score
after CABG (Figure 6) but yielded a lower sensitivity
and specificity for predicting global functional recovery.
Four or more viable segments predicted ≥3% improve-
ment in LVEF with a sensitivity of 76%, specificity of
42% (AUC 0.722, p = 0.04), clearly inferior to the num-
ber of viable+normal segments.
Finally, in line with convention we also examined a 5%
threshold for improvement in LVEF, where 10 or more
viable+normal segments had a sensitivity of 93%, specifi-
city 49%, positive predictive value 56%, negative predic-
tive value 90% and AUC 0.75, p = 0.02. Six patients who
w e r ed e f i n e da tt h e3 %l e v e lf o ri m p r o v e m e n ti nL V E F
did not meet criteria for improvement at the 5% level.
In these intermediate patients, ΔEF was +4 ± 0.6%,
ΔEDVI -16 ± 15 ml.m
-2, ΔESVI -13 ± 10 ml.m
-2.
Discussion
The most important findings of this single centre study
are: Using a 16 segment model and a definition of seg-
mental viability equaling <50% of transmural extent, the
number of viable+normal segments demonstrated a lin-
ear relationship with improvement in ejection fraction
and was able to predict patients with an overall
improvement in EF of ≥3% at 6 months with high sensi-
tivity and specificity. Significant recovery of global func-
tion and positive remodeling was present in patients
with at least 10 viable+normal segments, but not in
those with less than 10 viable+normal segments. These
findings are of direct clinical relevance for clinicians
Figure 4 Panel i. Correlation between the number of viable+normal segments and change in EF at 6 months (Δ EF). Panel ii. Scatter
plot showing the relationship between the number viable segments and change in EF at 6 months.
Table 2 Univariate and multivariate analyses for the
prediction of global functional recovery following
coronary artery bypass grafting
Univariate
analysis
Multivariate
analysis
r p Beta p
Number of viable+normal segments 0.67 < 0.001 1.298 < 0.001
Number of viable segments 0.31 0.08
% of LAD territory viable 0.35 0.05
Mean duration to 3rd CMR (days) 0.35 0.04
Number of viable segments was defined as segments <50% transmural extent
of late gadolinium enhancement. CMR, cardiovascular magnetic resonance;
LAD, left anterior descending coronary artery.
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with impaired LV function in everyday practice.
Prediction of regional functional recovery
The study by Kim et al.[ 5 ]w a sf i r s tt od e m o n s t r a t ea
progressive loss of functional recovery with increasing
transmural extent of LGE. Furthermore, they demon-
strated that although 79% of segments without evidence
of scar had improved contractility at 3 months, still a
significant proportion had not. Similar work in patients
with normal pre-operative EF imaged at 6 months
found a slightly higher rate of functional recovery in
segments without pre-existing LGE (82%)[14]. We simi-
larly expected that imaging later and excluding patients
with procedure related injury, would again optimize the
proportion of viable segments with functional recovery
after CABG. However, only 73% of unscarred segments
in our cohort recovered. Our group differed from both
that described by Kim et al.[5] and Selvanayagam et al.
[14] in that our mean LVEF was lower (38 vs. 43 or
61%), and with a greater proportion of both dysfunc-
tional and scarred segments. With a higher prevalence
of scar, our finding that the number of scarred segments
affected recovery of viable segments, may explain our
lower rates of regional functional recovery.
Prediction of global functional recovery
We found that the number of viable+normal segments
demonstrated a linear relationship with functional
recovery and was the only independent predictor of the
change in LVEF at 6 months, while the number of viable
segments was not. Furthermore, other baseline variables
such as mass of LGE did not demonstrate association
with overall functional recovery. However, recruited
patients included those with evidence of recent acute
coronary syndrome, and myocardial infarction defined
by CMR undergoes some degree of remodeling and con-
traction with age. Given the varying age of the myocar-
dial scar in our patients, the lack of association is
unsurprising.
Rizello et al. [15] using DSE, and Kim et al. [5] using
LGE, first showed a linear relationship between the
number of viable segments and the change in EF after
revascularisation, although their analysis was not based
on a 16 segment model, did not examine whether there
is a cut off for the number of segments that predicted
improvement of global function and did not include
assessment of the sum of viable+normal segments. How-
ever, patients with documented viability often fail to
recover global function subsequent to revascularisation.
Studies investigating the diagnostic performance of via-
bility assessment by different imaging modalities have
shown that they are generally sensitive (81-93%) but less
specific (58-80%)[16]. The lower specificity may be
because of incorrect labeling of non viable segments
(false positive), or for other reasons not relating to the
imaging modality, including procedural injury (such
patients were excluded in our study to eliminate this
effect) [14], incomplete revascularisation, LV remodeling
[17], and tethering by adjacent scarred segments[18].
Figure 5 ROC analysis for the threshold of viable segments
that predict global functional recovery. Legend shows various
transmural extent of LGE. Optimal diagnostic performance was
achieved with ≥10 viable+normal segments (segments affected by
<50% LGE).
Table 3 Remodeling in patients subsequent to surgery
Pre-op 6 months Mean difference p value
≥10 segments viable+normal (n = 22)
EDVI(ml.m
-2) 116 ± 32 105 ± 32 12 ± 23 0.03
ESVI(ml.m
-2) 74 ± 32 59 ± 29 15 ± 17 0.001
EF(%) 39 ± 11 46 ± 11 7 ± 5 p < 0.001
<10 segments viable+normal (n = 11)
EDVI(ml.m
-2) 122 ± 35 119 ± 38 2 ± 10 0.50
ESVI(ml.m
-2) 79 ± 34 79 ± 39 -1 ± 15 0.87
EF(%) 38 ± 11 37 ± 12 1 ± 6 0.59
EF, ejection fraction; ESVI, end systolic volume index; EDVI, end diastolic volume index. Viable defined as <50% transmural extent of late gadolinium
enhancement in each segment.
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cal revascularisation was first described by Yamaguchi et
al.[19] They identified that significant pre-operative LV
dilation (ESVI >100ml.m
-2) was associated with a poor
post-operative outcome, although no measure of viabi-
lity was made in this study. Further to this, Bax et al.
[17] suggested that in patients with substantial viability
(≥25% LV), sub groups with extensive pre-operative
remodeling (ESV ≥140 ml) do not show substantial
improvement in LVEF following CABG. In a cohort
comparable to the latter study, we found no relationship
between pre-operative ESVI and change in either global
or regional function after revascularisation. However,
our numbers are relatively small and it is conceivable
that in a larger study ESVI may emerge as a secondary
determinant of change in LVEF.
Finally, our finding that the number of viable+normal
segments was related to recovery in other viable seg-
ments supports the notion that tethering by scar tissue
may prevent regional and global recovery.
Analysis based on number of viable segments vs. number
of viable+normal segments
Previous studies have based prediction of global recov-
ery on the number of viable segments (defined as seg-
ments that are dysfunctional but viable, with the ability
to recover after revascularisation)[3,9], but our study
introduces the concept that the sum of viable+normal
segments may be a better predictor. To illustrate this,
let us consider two hypothetical patients. Patient A has
4 viable, 7 non-viable and 3 normal segments, while
patient B has 4 viable, 0 non-viable and 10 normal seg-
ments. The number of viable segments is the same (4)
for both patients, but the sum of viable+normal seg-
ments is 7 vs. 14. Intuitively, prognosis of these patients
will be different post CABG. Thus, in our cohort, we
analysed the predictive power of both the number of
viable segments and the sum of viable+normal seg-
ments. This point is best exemplified in the current
work in patients with mild LV dysfunction, few dysfunc-
tional segments but in whom there was still a measur-
able improvement in LVEF at 6 months (Large circles:
Figure 5, panels i and ii). Similar work from our group
in patients with normal LV function showed similar
improvement despite only 20% of analyzed segments
being dysfunctional prior to surgery; with LVEF improv-
ing from 61% ± 11 to 67% ± 10 at 6 months. We
hypothesize that visual assessment misses subtle LV sys-
tolic dysfunction, but the improvement is still detected
by highly reproducible means such as volume assess-
ment by CMR.
When examining change in regional wall motion
scores, the number of viable (but not including normal)
segments showed the better association. The latter is
likely because analysis of change in regional wall motion
score effectively excludes segments with normal baseline
function, correlating only improved dysfunctional seg-
ments with the number of viable segments, hence the
better association.
To include only viable segments in a reporting algo-
rithm for overall functional improvement presumes that
segments with normal baseline function sustain no
further improvement after revascularisation and make
no contribution to an increase in EF. Our data suggest
that analysis should incorporate the sum of viable+nor-
mal, i.e. all segments able to contribute to the end-point.
Finally, although convention defined a threshold of 5%
for clinically significant improvement in LVEF, this is
not founded on prognostic data but more what was felt
to be clinically relevant, which in the main part is deter-
mined by the reproducibility of transthoracic echo and
L Va n g i o g r a p h y .C M Ri sa b l et od e t e c ta3 %c h a n g ei n
LVEF with certainty[13]. In the current study, we found
that using a 5% threshold for improvement in LVEF
missed several patients with significant (>10%) reduction
in overall LV cavity size. Neither the 3% nor the 5%
threshold has been shown to be of prognostic impor-
tance. Furthermore, Senior et al. [20] determined that
an improvement in LV geometry, not 5% improvement
in LVEF, was associated with improved outcome after
CABG, and they conclude that any degree of LV remo-
deling is likely to be associated with a survival benefit.
Any reproducibly detectable improvement in function
after CABG is likely to be relevant to patients.
Figure 6 Correlation between the mean improvement in mean
regional wall motion score and the number of viable
segments.
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The major limitation of this study is the small sample
size, and these findings, although interesting, should be
considered preliminary. Follow up angiography was not
undertaken as part of this study, and long-term graft
patency cannot be excluded as a confounding factor. By
chance, patients with significant improvement in LVEF
had a statistically greater duration between surgery and
the 3
rd CMR scan. However, in practice, the difference
was small and is unlikely to be of any clinical or biologi-
cal relevance[21]. Previous studies have used an arbi-
trary threshold of 5%, we however chose a threshold for
functional recovery based upon the reproducibility of
the technique[13]. However, neither the 3% nor the 5%
improvement in ejection fraction have been shown to
translate to an improved outcome after surgery.
Conclusions
Our study suggests that the presence of 10 or more
viable plus normal segments, based upon the AHA 16
segment format and defined as <50% transmural scar,
predicts significant long term recovery of global LV
function in patients with impaired EF undergoing
CABG. This finding is important, and may provide a
simple approach to identify those patients who derive
functional and prognostic benefit from CABG.
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